Protalix is a publicly traded biotechnology company
(NYSE Amex: PLX),
that is producing recombinant therapeutic proteins through the ProCellEx™ plant cell system.
HOME PAGE
ABOUT US
Corporate Profile
Market Needs
Protalix Advantage
Management Team
Scientific Advisory Board
Press Room
Careers
TECHNOLOGY
ProCellEx Overview
Platform Technology
Protein Production
PRODUCT DEVELOPMENT
taliglucerase alfa (UPLYSO)
Pipeline Products
PARTNERSHIPS
INVESTORS
Corporate Strategy
Board of Directors
Management Team
Stock Information
Corporate Governance
Filings
Press Releases
FAQs
EVENT CALENDER
CONTACT US
Patients
Investor Relations
EVENT CALENDER
EVENT CALENDER
Date
Event
Conference Location
February 10-12, 2010
6th Annual Lysosomal Disease Network: WORLD Symposium
Miami, Florida
May 3-6, 2010
Bio Conference 2010
Chicago
May 16, 2010
Oppenheimer 11th Annual Israeli Conference
Tel Aviv, Israel
June 14-16, 2010
ILSI Biomed 2010 Conference
Tel Aviv, Israel
August 10-12, 2010
30th Annual Global Growth Conference
Boston, Massachusetts
© 2007 Protalix Biotherapeutics. All Rights Reserved.